Phase 3 Study of KHK7580 (A Long-term Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis)

Trial Profile

Phase 3 Study of KHK7580 (A Long-term Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis)

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Evocalcet (Primary)
  • Indications Secondary hyperparathyroidism
  • Focus Adverse reactions; Registrational
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 02 Jul 2017 Status changed from recruiting to completed.
    • 24 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 18 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top